Topics

Glioblastoma | Treatment | Clinical trials | Extracellular particles

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Extracellular particles

Youngblood MW, Kumari A, Kang YT, Gould A, Habashy K, Gomez M, Lingamarla H, Morey T, Chen L, Congivaram H, Ward R, Zhang H, Sears TK, McCortney K, Pituch KC, Torres Ponce EM, Zarrieneh A, Nieves M, Vandermolen S, Primdahl D, Dixit K, Lukas RV, Kumthekar P, Dmello C, Bouchoux G, Canney M, Amidei C, Stupp R, Nagrath S, Sonabend AM.
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel.
Nat Commun. 2025 Dec 16;16(1):11045. doi: 10.1038/s41467-025-65681-4. PMID: 41402297. Interventional study.